An AAGAB-to-CCDC32 handover mechanism controls the assembly of the AP2 adaptor complex.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
20 Aug 2024
Historique:
medline: 15 8 2024
pubmed: 15 8 2024
entrez: 15 8 2024
Statut: ppublish

Résumé

Vesicular transport relies on multimeric trafficking complexes to capture cargo and drive vesicle budding and fusion. Faithful assembly of the trafficking complexes is essential to their functions but remains largely unexplored. Assembly of AP2 adaptor, a heterotetrameric protein complex regulating clathrin-mediated endocytosis, is assisted by the chaperone AAGAB. Here, we found that AAGAB initiates AP2 assembly by stabilizing its α and σ2 subunits, but the AAGAB:α:σ2 complex cannot recruit additional AP2 subunits. We identified CCDC32 as another chaperone regulating AP2 assembly. CCDC32 recognizes the AAGAB:α:σ2 complex, and its binding leads to the formation of an α:σ2:CCDC32 ternary complex. The α:σ2:CCDC32 complex serves as a template that sequentially recruits the µ2 and β2 subunits of AP2 to complete AP2 assembly, accompanied by CCDC32 release. The AP2-regulating function of CCDC32 is disrupted by a disease-causing mutation. These findings demonstrate that AP2 is assembled by a handover mechanism switching from AAGAB-based initiation complexes to CCDC32-based template complexes. A similar mechanism may govern the assembly of other trafficking complexes exhibiting the same configuration as AP2.

Identifiants

pubmed: 39145939
doi: 10.1073/pnas.2409341121
doi:

Substances chimiques

Adaptor Protein Complex 2 0
Molecular Chaperones 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2409341121

Subventions

Organisme : HHS | National Institutes of Health (NIH)
ID : GM126960
Organisme : HHS | National Institutes of Health (NIH)
ID : DK124431
Organisme : HHS | National Institutes of Health (NIH)
ID : GM138685

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Chun Wan (C)

Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.

Harrison Puscher (H)

Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.

Yan Ouyang (Y)

Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.

Jingyi Wu (J)

Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.

Yuan Tian (Y)

Department of Biological Sciences and Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306.

Suzhao Li (S)

Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045.

Qian Yin (Q)

Department of Biological Sciences and Institute of Molecular Biophysics, Florida State University, Tallahassee, FL 32306.

Jingshi Shen (J)

Department of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH